In cooperation with Martin Zacharias, Professor of Theoretical Biophysics at the TU Munich, Springer aims at developing chemical substances to inhibit or enhance the response. These substances could be used either in vaccines to boost the immune reaction or in drugs administered to transplant patients to suppress a possible rejection of the organ. The project is funded by the German Research Foundation (DFG) with a total of 225 000 Euros over an initial three-year period.
Vaccination to prevent diseases such as polio and seasonal influenza is commonplace in Europe today. Just a little needle-prick and one is protected from infections like flue or measles. Weakened or killed forms of the pathogen (the virus or bacterium) are contained in the vaccine to stimulate the body's immune response. White blood cells recognize the pathogen as foreign, destroy it, and remember its structure to be able to identify and kill the same kind of virus when encountered again. These facts have been known for a while. However, the chemical processes that take place inside each cell to trigger the immune reaction are still not understood in detail.
For almost ten years, Sebastian Springer, Jacobs University Professor of Biochemistry and Cell Biology, has been conducting research to better understand and influence these processes. His research focuses on the so called "major histocompatibility complex (MHC) class I molecules", which play a central role in the mammalian immune defense against viruses, intracellular bacteria, and cancer.
As a virus replicates inside a cell, it produces peptides (small pieces of proteins). These peptides bind to MHC class I molecules, which are present inside all cells. The binding process activates the molecule to travel to the cell surface, where they are surveyed by white blood cells called "cytotoxic T lymphocytes" (CTL). If the CTL detect that unusual peptides are bound to the molecules, they induce the infected cell to undergo controlled cell death. This way, the production site of the virus is eliminated and it can't spread out further.
During his studies, Springer discovered a chemical substance that enhances the binding process between MHC class I molecules and peptides. "Picture the part of the molecule that the peptide docks onto as the mouth of a venus flytrap," Springer explains. "The substance we discovered is able to keep this mouth - the binding site - open and thus makes it much easier for the peptide to bind to the molecule. As the binding rate increases, more molecules are triggered to travel to the cell surface and an infected cell can be faster detected and eliminated."
Although highly unstable and not yet ready for use in vaccines or other drugs, the newly discovered substance provides an ideal basis for further research. "By understanding how the substance keeps the binding site open we can begin to develop similar but more stable substances for the use in therapeutic drugs," says Springer.
Combining bioinformatics and biochemistry approaches, Springer and his team will develop and analyze various chemical components in respect of their influence on the peptide-molecule binding process. In a first step, Martin Zacharias, Professor of Theoretical Biophysics at the TU Munich, will recreate the chemical structure of the substances in a computer simulation and imitate a possible interaction between substance and molecule. In a second step, the substances that accelerated or retarded the binding process will then be tested in living cells in Springer's laboratory and further developed.
"If we find a chemical substance that is stable enough to travel into cells when administered in combination with a vaccine or other drug," says Springer, "we could be able to control the immune reaction on a cellular level and thus enhance the affectivity of viral vaccination or, by suppressing the immune reaction, increase the success rate of organ transplantations and therapies used for autoimmune disease patients."Contact at Jacobs University:
Dr. Kristin Beck | idw
Lipid nanodiscs stabilize misfolding protein intermediates red-handed
18.12.2017 | Technische Universität München
Single-stranded DNA and RNA origami go live
15.12.2017 | Wyss Institute for Biologically Inspired Engineering at Harvard
A study carried out by an international team of researchers and published in the journal Physical Review X shows that ion-trap technologies available today are suitable for building large-scale quantum computers. The scientists introduce trapped-ion quantum error correction protocols that detect and correct processing errors.
In order to reach their full potential, today’s quantum computer prototypes have to meet specific criteria: First, they have to be made bigger, which means...
Since 2016, German and Spanish researchers, among them scientists from the University of Göttingen, have been hunting for exoplanets with the “Carmenes”...
DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.
Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...
MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.
Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...
Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...
11.12.2017 | Event News
08.12.2017 | Event News
07.12.2017 | Event News
18.12.2017 | Information Technology
18.12.2017 | Physics and Astronomy
18.12.2017 | Agricultural and Forestry Science